Provided by Tiger Trade Technology Pte. Ltd.

Capricor Therapeutics

9.06
-0.3600-3.82%
Post-market: 9.05-0.0100-0.11%19:59 EDT
Volume:3.26M
Turnover:29.57M
Market Cap:526.74M
PE:-3.67
High:9.36
Open:9.30
Low:8.96
Close:9.42
52wk High:40.37
52wk Low:2.96
Shares:58.14M
Float Shares:45.54M
Volume Ratio:1.21
T/O Rate:7.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4659
EPS(LYR):-2.2601
ROE:-73.70%
ROA:-33.63%
PB:2.14
PE(LYR):-4.01

Loading ...

Capricor Therapeutics Announces Extension of Pdufa Target Action Date as FDA Continues Review of Deramiocel Bla

THOMSON REUTERS
·
Aug 24

Kaos Capital urges Capricor shareholders to support immediate board meeting

TIPRANKS
·
Aug 21

Kaos Capital : Plans to Nominate Two Independent Director Candidates at Capricor & to Seek Board-Led M&a and Strategic Alternatives Committee

THOMSON REUTERS
·
Aug 21

Kaos Capital: Demands an Immediate Meeting, Board Change, and Capital-Preservation Plan at Capricor

THOMSON REUTERS
·
Aug 21

Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and Capricor Therapeutics (CAPR)

TIPRANKS
·
Aug 16

Capricor Therapeutics Remains Optimistic about Deramiocel FDA Approval

Benzinga Earnings
·
Aug 14

Sector Update: Healthcare Stocks Flat to Lower Pre-Bell Friday

MT Newswires Live
·
Aug 14

Analysts Offer Insights on Healthcare Companies: Alumis Inc. (ALMS), Cabaletta Bio (CABA) and Capricor Therapeutics (CAPR)

TIPRANKS
·
Aug 14

U.S. Stocks on the MOVE-Reddit, Capricor Therapeutics, Birkenstock

Reuters
·
Aug 14

Cantor Fitzgerald Upgrades Capricor Therapeutics to Overweight From Neutral, Adjusts PT to $28 From $3.50

MT Newswires Live
·
Aug 14

Top Premarket Gainers

MT Newswires Live
·
Aug 14

Capricor Shares Skyrocket as FDA Agrees to Review New Duchenne Drug Data

Reuters
·
Aug 14

Capricor Therapeutics Shares up 105.9% Premarket After FDA Agrees to Review New Duchenne Drug Data

THOMSON REUTERS
·
Aug 14

Capricor Therapeutics Raised to Overweight from Neutral by Cantor Fitzgerald

Dow Jones
·
Aug 14

Capricor Therapeutics (CAPR) Shares Soar Over 67% After Hours: Here's Why

Benzinga Earnings
·
Aug 14

Capricor Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Capricor Therapeutics Q2 EPS $(0.70) Misses $(0.58) Estimate

Benzinga Earnings
·
Aug 14

Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Aug 14

U.S. Earnings Preview: After Market Close Aug. 13

Dow Jones
·
Aug 14

Capricor Therapeutics Lawsuit Focuses on Deramiocel Disclosures After CAPR Stock Drops

TIPRANKS
·
Aug 14